Research and Clinical Trials
As Director of Mount Sinai’s Sarcoma Cancer Program, Dr. Maki’s expertise in novel therapies for the treatment of soft-tissue and bone sarcomas has led him to investigate new drugs to attack molecular targets for this rare and varied group of cancers. He is also interested in novel clinical trial designs and in translational laboratory research to identify new targets that will inform future clinical trials.
Many Mount Sinai patients have the opportunity to participate in such clinical trials and to receive promising new therapies not otherwise available. Participation in clinical trials is completely voluntary.
To find currently open clinical trials for sarcoma, please visit the Clinical Trials and Research Studiesarea of our Web site.
To schedule an appointment, call 800-MD-SINAI (800-637-4624).
To contact one of our doctors directly, please see his or her individual profile for contact information.